Ledger.Open graph →
SEC Form D · filed February 24, 2016

Renibus Therapeutics, Inc

Offering
$10.0M
Sold
$2.9M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
LANTANA, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Dale Jones · Lantana, TXDirectorJennifer D. Rasmussen · Lantana, TXDirectorNels D. Bergmark · Lantana, TXExecCarlos Guillem · Lantana, TXExec · DirectorHarpreet Kaur · Lantana, TXExec · DirectorJocelyn D. Keyser · Lantana, TXDirectorJason L. Yoffy · Troy, MIExec · DirectorAlexander Bullington · Forest Hill, MDDirectorLarry L. Adloff · Troy, MIExec · DirectorArthur B. Mcwood · Troy, MIDirectorGregory Dinardo · Austin, TXExecTimothy L. Hoel · Troy, MIDirectorJohn B. Coppolino · Troy, MIExecLawrence B. Carlson · Troy, MIDirectorDaniel J. Jenuwine · Troy, MIExec · DirectorJim M. Hodge · Henderson, NVExec · DirectorRandon M. Hansen · Henderson, NVDirectorMark M. Stoker · Henderson, NVDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗